Qiagen N.V. (QIA.DE)
45.02 EUR +0.04%
Qiagen N.V. rose 0.04% in the latest session, at 45.02 EUR. By market cap it is number 6 of the 6 health care stocks on the DAX 40 heatmap. Its trailing P/E of 26.6 is above the median of those peers (19.8). The price is 5.4% below its 52-week high.
Key numbers
- Price
- 45.02 EUR
- Day change
- +0.04% (0.02)
- Market cap
- 9.3B EUR
- P/E (trailing)
- 26.6
- P/E (forward)
- 19.6
- Dividend yield
- 0.68%
- 50-day average
- 39.79
- 200-day average
- 36.56
- 52-week range
- 27.56 – 47.60
- Next earnings
- 4 Nov 2026
- Dividend per share (annual)
- 0.31 EUR
Data as of 3 Nov 2026, 17:35 CET. Market data may be delayed.
Qiagen N.V. over the past year
From daily closing prices. The highest close in the period was 46.43 EUR on 26 Jan 2026, the lowest 28.11 EUR on 8 May 2026.
| 1 month | 3 months | 6 months | Year to date | 1 year |
|---|---|---|---|---|
| +11.42% | +24.90% | +55.29% | +10.07% | +7.80% |
| Month | Close (EUR) | Change |
|---|---|---|
| November 2026 | 45.02 | -0.16% |
| October 2026 | 45.09 | +16.45% |
| September 2026 | 38.72 | +3.99% |
| August 2026 | 37.24 | +4.24% |
| July 2026 | 35.72 | +5.37% |
| June 2026 | 33.90 | +7.13% |
| May 2026 | 31.65 | +8.99% |
| April 2026 | 29.03 | -16.43% |
| March 2026 | 34.74 | -17.19% |
| February 2026 | 41.96 | -5.96% |
| January 2026 | 44.62 | +9.10% |
| December 2025 | 40.90 | -5.52% |
Health care peers
Qiagen N.V. is on the DAX 40 heatmap (Health care). How it compares with the other health care stocks there, by market cap:
| Company | Today | Market cap | P/E |
|---|---|---|---|
| Merck KGaA MRK.DE | -0.57% | 64.8B EUR | 27.4 |
| Bayer Aktiengesellschaft BAYN.DE | +3.64% | 50.9B EUR | — |
| Siemens Healthineers AG SHL.DE | -0.12% | 48.5B EUR | 22.0 |
| Fresenius SE & Co. KGaA FRE.DE | +0.47% | 27.5B EUR | 17.6 |
| Fresenius Medical Care AG FME.DE | -3.60% | 10.5B EUR | 11.8 |
| Qiagen N.V. QIA.DE | +0.04% | 9.3B EUR | 26.6 |
More on QIA
Open QIA.DE in zysk for the live chart, news, earnings and dividends, and ask the AI why it moved: it answers in a few lines with sources and a chart (how zysk's AI stock research works). zysk explains facts, news and risks; it is not investment advice.